Which of the following is intended for use against HCV?
Merimepodib
Viramidine
Ribavirin
All of the above
Investigational agents for the treatment of HCV infection are multiple and include inhibitors of the HCV RNA polymerase such as valopicitabine, PIs such as telaprevir, the ribavirin analogs merimepodib and viramidine, an anti-aminophospholipid antibody, a caspase inhibitor, and the immunomodulator thymosin alpha-1. Ref: Katzung 11th edition Chapter 49.